{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/back-pain-low-without-radiculopathy/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"089c38f6-7158-5d2f-9683-e1e16a2e7bc9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field a953db85-8ed6-47f6-a9e6-a7f201888882 --><h2>Evidence exclusion criteria</h2><!-- end field a953db85-8ed6-47f6-a9e6-a7f201888882 -->","summary":null,"htmlStringContent":"<!-- begin item 99718364-1bb2-4dbd-b9e8-a7f20187a3cf --><!-- begin field 9e634105-3a0d-4295-83ab-a7f201888882 --><h2>Our policy</h2><!-- end field 9e634105-3a0d-4295-83ab-a7f201888882 --><!-- begin field 361d5444-7413-4b94-8491-a7f201888882 --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 361d5444-7413-4b94-8491-a7f201888882 --><!-- begin field 86a4885e-fe1d-4926-8906-a7f201888882 --><h2>Standard exclusions for scoping literature:</h2><!-- end field 86a4885e-fe1d-4926-8906-a7f201888882 --><!-- begin field d739ad9b-4d4a-4c95-998d-a7f201888882 --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field d739ad9b-4d4a-4c95-998d-a7f201888882 --><!-- begin field 63e3b18b-d5ff-4cea-b1a5-a7f201888882 --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 63e3b18b-d5ff-4cea-b1a5-a7f201888882 --><!-- begin field 4bce6aba-01ef-4f93-ba8f-a7f201888882 --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field 4bce6aba-01ef-4f93-ba8f-a7f201888882 --><!-- end item 99718364-1bb2-4dbd-b9e8-a7f20187a3cf -->","topic":{"id":"67ec8276-483f-5bd3-a1d4-abc190687cec","topicId":"9b18de7f-5dbf-47fa-b614-8130c5721d6c","topicName":"Back pain - low (without radiculopathy)","slug":"back-pain-low-without-radiculopathy","lastRevised":"Last revised in November 2020","chapters":[{"id":"d8279135-bdfb-5f8d-a638-9f5c15e8e31e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94f53f0f-68b9-57d2-bb9b-9205b4128d2a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1e14b540-8ee6-5ec6-a360-b55991b947f3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6ce99d9d-152d-5b24-87b1-279f7cca5449","slug":"changes","fullItemName":"Changes"},{"id":"98f67efe-dc7d-5678-ad87-be8f6369b281","slug":"update","fullItemName":"Update"}]},{"id":"4fa9a83d-808c-53a6-95a7-4906ba0762b3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3b4be10b-9039-5c16-9f5c-e53279f4ef3a","slug":"goals","fullItemName":"Goals"},{"id":"ac362b69-f985-5883-8d14-7b25b4cd4c92","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1581e495-09a8-5389-a60c-1a3b417b8be7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5ffd119a-f7fe-5e5d-9891-d3e921d92d40","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b051c066-56d4-5c85-8b28-98014a97b749","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"302a3eb3-4a2b-550a-89a6-cd26e0eef14a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bd777de4-3ef6-529d-bcbf-8bf6aa892e99","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2e9191b9-9306-5480-be62-c1f812b84b32","slug":"definition","fullItemName":"Definition"},{"id":"810863bb-72c6-58eb-bb75-3e2f1ee214b2","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b2234c07-e852-5713-8078-e978d40b2b82","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"16569068-7bdd-5aad-b47c-7e935d6c6254","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a40462ae-8085-5573-a267-170ee6539bbb","slug":"complications","fullItemName":"Complications"}]},{"id":"140fe6e6-d5e6-56f6-a4ac-d1791b9a1de1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6540e013-bdca-57be-8415-3dacd0fd448a","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b2bb39a7-3f14-593c-a0bb-11b6229e9193","slug":"red-flag-symptoms-signs","fullItemName":"Red flag symptoms and signs"}]},{"id":"41781ac6-3970-5128-9f67-8103d95876c0","fullItemName":"Management","slug":"management","subChapters":[{"id":"1d96563b-1a08-575c-a108-6e566028123f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"18c68aea-1807-5bbb-a514-d9f773a881fb","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"53da469c-6c3c-5af5-b251-e252f8f3ae47","slug":"diazepam","fullItemName":"Diazepam"},{"id":"e815c8fc-c6d6-5168-aacd-92b8545caf45","slug":"nonsteroidal-anti-inflammatory-drugs","fullItemName":"Nonsteroidal anti-inflammatory drugs"},{"id":"9aaa155a-4c14-58c4-a24d-a0d7594586c1","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"f098cbb6-72ba-503d-b622-a02915fe6668","slug":"weak-opioids","fullItemName":"Weak opioids"}]},{"id":"9607837f-245f-5649-86a7-425a90fe7c11","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c264a034-a901-521f-83d9-6e19cfe6295a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"12ec6fad-43c6-5117-b906-d169335441b2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d262f13b-ed13-541d-9ca8-e7075aebd557","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"089c38f6-7158-5d2f-9683-e1e16a2e7bc9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"62a8100d-ffe9-5e3b-8ca4-071a242c2406","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6dbc5aaa-df51-510a-af88-268983a5b382","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"81117569-d1c8-597d-a361-fa9822c7a4f7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c264a034-a901-521f-83d9-6e19cfe6295a","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}